In contrast, some TRIMs facilitate tumor progression by suppressing p53 activity; for example, acetylated TRIM29 can interact with p53 to change the nuclear localization of p53, thereby inhibiting p53 activity and promoting cell proliferation (Yuan et al., 2010). Here, TP53 is linked to neoplasm.